141 related articles for article (PubMed ID: 34750857)
1. PAK1 and PAK2 in cell metabolism regulation.
Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
[TBL] [Abstract][Full Text] [Related]
2. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
3. Group I p21-activated kinases in leukemia cell adhesion to fibronectin.
Kuželová K; Obr A; Röselová P; Grebeňová D; Otevřelová P; Brodská B; Holoubek A
Cell Adh Migr; 2021 Dec; 15(1):18-36. PubMed ID: 33464167
[TBL] [Abstract][Full Text] [Related]
4. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
[TBL] [Abstract][Full Text] [Related]
5. Late-onset megaconial myopathy in mice lacking group I Paks.
Joseph GA; Hung M; Goel AJ; Hong M; Rieder MK; Beckmann ND; Serasinghe MN; Chipuk JE; Devarakonda PM; Goldhamer DJ; Aldana-Hernandez P; Curtis J; Jacobs RL; Krauss RS
Skelet Muscle; 2019 Feb; 9(1):5. PubMed ID: 30791960
[TBL] [Abstract][Full Text] [Related]
6. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
[TBL] [Abstract][Full Text] [Related]
7. The p21-activated kinase 2 (PAK2), but not PAK1, regulates contraction-stimulated skeletal muscle glucose transport.
Møller LLV; Nielsen IL; Knudsen JR; Andersen NR; Jensen TE; Sylow L; Richter EA
Physiol Rep; 2020 Jun; 8(12):e14460. PubMed ID: 32597567
[TBL] [Abstract][Full Text] [Related]
8. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
Bright MD; Garner AP; Ridley AJ
Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
[TBL] [Abstract][Full Text] [Related]
9. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
[TBL] [Abstract][Full Text] [Related]
10. The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.
Nuche-Berenguer B; Ramos-Álvarez I; Jensen RT
Biochim Biophys Acta; 2016 Jun; 1862(6):1122-36. PubMed ID: 26912410
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
[TBL] [Abstract][Full Text] [Related]
12. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.
Coniglio SJ; Zavarella S; Symons MH
Mol Cell Biol; 2008 Jun; 28(12):4162-72. PubMed ID: 18411304
[TBL] [Abstract][Full Text] [Related]
13. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.
Licciulli S; Maksimoska J; Zhou C; Troutman S; Kota S; Liu Q; Duron S; Campbell D; Chernoff J; Field J; Marmorstein R; Kissil JL
J Biol Chem; 2013 Oct; 288(40):29105-14. PubMed ID: 23960073
[TBL] [Abstract][Full Text] [Related]
14. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
Sun X; Su VL; Calderwood DA
J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
[TBL] [Abstract][Full Text] [Related]
15. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
16. P21-activated kinase in inflammatory and cardiovascular disease.
Taglieri DM; Ushio-Fukai M; Monasky MM
Cell Signal; 2014 Sep; 26(9):2060-9. PubMed ID: 24794532
[TBL] [Abstract][Full Text] [Related]
17. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.
Weisz Hubsman M; Volinsky N; Manser E; Yablonski D; Aronheim A
Biochem J; 2007 Jun; 404(3):487-97. PubMed ID: 17355222
[TBL] [Abstract][Full Text] [Related]
18. p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway.
Radu M; Lyle K; Hoeflich KP; Villamar-Cruz O; Koeppen H; Chernoff J
Mol Cell Biol; 2015 Dec; 35(23):3990-4005. PubMed ID: 26391956
[TBL] [Abstract][Full Text] [Related]
19. Potential compensation among group I PAK members in hindlimb ischemia and wound healing.
Elsherif L; Ozler M; Zayed MA; Shen JH; Chernoff J; Faber JE; Parise LV
PLoS One; 2014; 9(11):e112239. PubMed ID: 25379771
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase D1 (PKD1) phosphorylation on Ser
Chang JK; Ni Y; Han L; Sinnett-Smith J; Jacamo R; Rey O; Young SH; Rozengurt E
J Biol Chem; 2017 Jun; 292(23):9523-9539. PubMed ID: 28408623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
